Phase II trial of the pan-deacetylase inhibitor panobinostat as a single agent in advanced relapsed/refractory multiple myeloma
- PMID: 22288662
- DOI: 10.3109/10428194.2012.661175
Phase II trial of the pan-deacetylase inhibitor panobinostat as a single agent in advanced relapsed/refractory multiple myeloma
Comment in
-
Pioneering studies of histone deacetylase inhibitors in myeloma: signals of activity set the stage for combination therapy trials.Leuk Lymphoma. 2012 Sep;53(9):1658-9. doi: 10.3109/10428194.2012.658571. Epub 2012 Feb 13. Leuk Lymphoma. 2012. PMID: 22260164 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical